Correlia Biosystems is a Y Combinator backed life science startup based in Berkeley, CA. We are developing a next generation proteomics platform to transform laborious and time-consuming immunoassays. Using lab-on-a-chip technology, we are creating the new standard for fast, automated, and multiplexed assays that put more critical data in the hands of researchers in basic science, pharma, diagnostics, and beyond.